Product Images Propafenone Hydrochloride

This text provides results from a clinical trial comparing the efficacy of Propafenone ER to a placebo. The data shows the number of events at various time points for both Propafenone ER and placebo groups. The study also tested the effects of different dosages of Propafenone ER. Patient closeout began on day 273 and lasted until day 300. One of the patients on 325 mg experienced an event on day 291, resulting in a significant decline in the Kaplan-Meier curves.*

This is a description of a medication called "Propafenone propalenne hydrociorids, USP". It comes in the form of extended-release capsules with each capsule containing 225 mg of the medication. Usual dosage information can be found in the package insert. The manufacturer is Zydus and it should be kept out of reach of children. The rest of the text is unclear or not relevant.*

This is a description of a drug named "Propafenone Hydrochloride" which comes in the form of extended-release capsules. The package contains 60 capsules, each of which contains 325mg of Propafenone Hydrochloride, USP. The package insert should be referred to for complete prescribing information. The drug must be stored at 20° to 25°C (66° to 77°F) and dispensed in a tight container. The package is child-resistant and manufactured by Cadla Healthcare Ltd., India.*

This text seems to be a medication label with instructions and warnings for usage. The medication is in the form of extended-release capsules in two different variants called Propafenone Hydrochloride and Snmmiiomn with specific sizes. The label contains instructions to dispense the medication in a defined container and warns to keep the product out of children's reach. The medication seems to be available only on prescription through Cadia Healthcare L, Kings.*